A Montpellier-based company is developing a promising project to treat concussions.
A Montpellier-based med-tech company specializing in neurology, Regenlife works in particular on Alzheimer’s disease, and more recently has turned its attention to the problem of acute concussion in high-level athletes. “Our originality lies in treating people with a non-invasive medical device that uses three-photon light-stimulation technology,” explains Regenlife CEO Dr. Patrice Cristofini. The treatment is called photobiomodulation.
It was almost by chance that Regenlife became interested in concussions. A machine left at the MHR to treat haematomas, and the sagacity of Philippe Malafosse who suggested that the med-tech company transpose its research on Alzheimer’s disease to the problems of concussions.
“With each session, the effect improves”.
“This stimulation reduces inflammation time. This acts directly on the neurons, explains Patrice Cristofini. We regenerate suffering cells. We have observed that not only do athletes feel good, but the effect improves with each session. ”
Concretely, the concussion patient wears a helmet fitted with pins which diffuses three red and infrared photon sources onto the area of the brain to be treated. Treatment takes place in 20-minute sessions, repeated one or more times. “It’s a non-invasive, pain-free device, and we’ve demonstrated that there are no side effects,” adds Patrice Cristofini.
“ The competition is global, and we need to be visible,” concludes Michaël Delafosse, Mayor of Montpellier and President of Montpellier Méditerranée Métropole.
